Cargando…
Targeting breast cancer with a combination of DNT and LAG3 checkpoint blockage and its mechanism
INTRODUCTION: The characteristics of the tumor immune microenvironment (TIME) are closely related to immunotherapy. Breast cancer can benefit from immunotherapy, and its TIME is still unclear. METHODS: We utilized mass cytometry to explore the immune cell heterogeneity in breast cancer. Double‐negat...
Autores principales: | Wang, Miao, Wei, Yuhan, Li, Yingrui, Li, Hongzhong, Jin, Jiangtao, Lu, Yuting, Li, Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274802/ https://www.ncbi.nlm.nih.gov/pubmed/35894707 http://dx.doi.org/10.1002/iid3.626 |
Ejemplares similares
-
DNT Cell-based Immunotherapy: Progress and Applications
por: Li, Yingrui, et al.
Publicado: (2020) -
Multi-Omics Analysis of the Anti-tumor Synergistic Mechanism and Potential Application of Immune Checkpoint Blockade Combined With Lenvatinib
por: Lu, Yuting, et al.
Publicado: (2021) -
LAG3 and its emerging role in cancer immunotherapy
por: Wang, Miao, et al.
Publicado: (2021) -
Directed Evolution of the Transcriptional Regulator DntR: Isolation of Mutants with Improved DNT-Response
por: Lönneborg, Rosa, et al.
Publicado: (2012) -
Targeting chemotherapy-resistant leukemia by combining DNT cellular therapy with conventional chemotherapy
por: Chen, Branson, et al.
Publicado: (2018)